Engagement of DYRK2 in proper control for cell division

References

• Lochhead PA, Sibbet G, Morrice N, Cleghon V. Activation-loop autophosphorylation is mediated by a novel transitional intermediate form of DYRKs. Cell 2005; 121:925-36; PMID:15960979; http://dx.doi.org/10.1016/j.cell.2005.03.034
   PubMed Web of Science ®Google Scholar
• Becker W, Weber Y, Wetzel K, Eirmbter K, Tejedor FJ, Joost HG. Sequence characteristics, subcellular localization, and substrate specificity of DYRK-related kinases, a novel family of dual specificity protein kinases. J Biol Chem 1998; 273:25893-902; PMID:9748265; http://dx.doi.org/10.1074/jbc.273.40.25893
   PubMed Web of Science ®Google Scholar
• Taira N, Nihira K, Yamaguchi T, Miki Y, Yoshida K. DYRK2 is targeted to the nucleus and controls p53 via Ser46 phosphorylation in the apoptotic response to DNA damage. Mol Cell 2007; 25:725-38; PMID:17349958; http://dx.doi.org/10.1016/j.molcel.2007.02.007
   PubMed Web of Science ®Google Scholar
• Wang Z, Liu P, Inuzuka H, Wei W. Roles of F-box proteins in cancer. Nat Rev Cancer 2014; 14:233-47; PMID:24658274; http://dx.doi.org/10.1038/nrc3700
   PubMed Web of Science ®Google Scholar
• Varjosalo M, Bjorklund M, Cheng F, Syvanen H, Kivioja T, Kilpinen S, Sun Z, Kallioniemi O, Stunnenberg HG, He WW, et al. Application of active and kinase-deficient kinome collection for identification of kinases regulating hedgehog signaling. Cell 2008; 133:537-48; PMID:18455992; http://dx.doi.org/10.1016/j.cell.2008.02.047
   PubMed Web of Science ®Google Scholar
• Weiss CS, Ochs MM, Hagenmueller M, Streit MR, Malekar P, Riffel JH, Buss SJ, Weiss KH, Sadoshima J, Katus HA, et al. DYRK2 negatively regulates cardiomyocyte growth by mediating repressor function of GSK-3beta on eIF2Bepsilon. PLoS One 2013; 8:e70848; PMID:24023715; http://dx.doi.org/10.1371/journal.pone.0070848
   PubMed Web of Science ®Google Scholar
• Woods YL, Cohen P, Becker W, Jakes R, Goedert M, Wang X, Proud CG. The kinase DYRK phosphorylates protein-synthesis initiation factor eIF2Bepsilon at Ser539 and the microtubule-associated protein tau at Thr212: potential role for DYRK as a glycogen synthase kinase 3-priming kinase. Biochem J 2001; 355:609-15; PMID:11311121
   PubMed Web of Science ®Google Scholar
• Taira N, Mimoto R, Kurata M, Yamaguchi T, Kitagawa M, Miki Y, Yoshida K. DYRK2 priming phosphorylation of c-Jun and c-Myc modulates cell cycle progression in human cancer cells. J Clin Invest 2012; 122:859-72; PMID:22307329; http://dx.doi.org/10.1172/JCI60818
   PubMed Web of Science ®Google Scholar
• Maddika S, Chen J. Protein kinase DYRK2 is a scaffold that facilitates assembly of an E3 ligase. Nat Cell Biol 2009; 11:409-19; PMID:19287380; http://dx.doi.org/10.1038/ncb1848
   PubMed Web of Science ®Google Scholar
• Jung HY, Wang X, Jun S, Park JI. Dyrk2-associated EDD-DDB1-VprBP E3 ligase inhibits telomerase by TERT degradation. J Biol Chem 2013; 288:7252-62; PMID:23362280; http://dx.doi.org/10.1074/jbc.M112.416792
   PubMed Web of Science ®Google Scholar
• Blasco MA. Telomeres and human disease: ageing, cancer and beyond. Nat Rev Genet 2005; 6:611-22; PMID:16136653; http://dx.doi.org/10.1038/nrg1656
   PubMed Web of Science ®Google Scholar
• Perez M, Garcia-Limones C, Zapico I, Marina A, Schmitz ML, Munoz E, Calzado MA. Mutual regulation between SIAH2 and DYRK2 controls hypoxic and genotoxic signaling pathways. J Mol Cell Biol 2012; 4:316-30; PMID:22878263; http://dx.doi.org/10.1093/jmcb/mjs047
   PubMed Web of Science ®Google Scholar
• Taira N, Yoshida K. Post-translational modifications of p53 tumor suppressor: determinants of its functional targets. Histol Histopathol 2012; 27:437-43; PMID:22374721
   PubMed Web of Science ®Google Scholar
• D'Orazi G, Cecchinelli B, Bruno T, Manni I, Higashimoto Y, Saito S, Gostissa M, Coen S, Marchetti A, Del Sal G, et al. Homeodomain-interacting protein kinase-2 phosphorylates p53 at Ser 46 and mediates apoptosis. Nat Cell Biol 2002; 4:11-9; PMID:11780126; http://dx.doi.org/10.1038/ncb714
   PubMed Web of Science ®Google Scholar
• Rinaldo C, Prodosmo A, Mancini F, Iacovelli S, Sacchi A, Moretti F, Soddu S. MDM2-regulated degradation of HIPK2 prevents p53Ser46 phosphorylation and DNA damage-induced apoptosis. Mol Cell 2007; 25:739-50; PMID:17349959; http://dx.doi.org/10.1016/j.molcel.2007.02.008
   PubMed Web of Science ®Google Scholar
• Taira N, Yamamoto H, Yamaguchi T, Miki Y, Yoshida K. ATM augments nuclear stabilization of DYRK2 by inhibiting MDM2 in the apoptotic response to DNA damage. J Biol Chem 2010; 285:4909-19; PMID:19965871; http://dx.doi.org/10.1074/jbc.M109.042341
   PubMed Web of Science ®Google Scholar
• Oda K, Arakawa H, Tanaka T, Matsuda K, Tanikawa C, Mori T, Nishimori H, Tamai K, Tokino T, Nakamura Y, et al. p53AIP1, a potential mediator of p53-dependent apoptosis, and its regulation by Ser-46-phosphorylated p53. Cell 2000; 102:849-62; PMID:11030628; http://dx.doi.org/10.1016/S0092-8674(00)00073-8
   PubMed Web of Science ®Google Scholar
• Wesierska-Gadek J, Gueorguieva M, Horky M. Roscovitine-induced up-regulation of p53AIP1 protein precedes the onset of apoptosis in human MCF-7 breast cancer cells. Mol Cancer Ther 2005; 4:113-24; PMID:15657359
   PubMed Web of Science ®Google Scholar
• Taira N, Yamaguchi T, Kimura J, Lu ZG, Fukuda S, Higashiyama S, Ono M, Yoshida K. Induction of amphiregulin by p53 promotes apoptosis via control of microRNA biogenesis in response to DNA damage. Proc Natl Acad Sci U S A 2014; 111:717-22; PMID:24379358; http://dx.doi.org/10.1073/pnas.1313675111
   PubMed Web of Science ®Google Scholar
• Cimmino A, Calin GA, Fabbri M, Iorio MV, Ferracin M, Shimizu M, Wojcik SE, Aqeilan RI, Zupo S, Dono M, et al. miR-15 and miR-16 induce apoptosis by targeting BCL2. Proc Natl Acad Sci U S A 2005; 102:13944-9; PMID:16166262; http://dx.doi.org/10.1073/pnas.0506654102
   PubMed Web of Science ®Google Scholar
• Smogorzewska A, Desetty R, Saito TT, Schlabach M, Lach FP, Sowa ME, Clark AB, Kunkel TA, Harper JW, Colaiacovo MP, et al. A genetic screen identifies FAN1, a Fanconi anemia-associated nuclease necessary for DNA interstrand crosslink repair. Mol Cell 2010; 39:36-47; PMID:20603073; http://dx.doi.org/10.1016/j.molcel.2010.06.023
   PubMed Web of Science ®Google Scholar
• Wang Y, Shang Y. Epigenetic control of epithelial-to-mesenchymal transition and cancer metastasis. Exp Cell Res 2013; 319:160-9; PMID:22935683; http://dx.doi.org/10.1016/j.yexcr.2012.07.019
   PubMed Web of Science ®Google Scholar
• Batlle E, Sancho E, Franci C, Dominguez D, Monfar M, Baulida J, Garcia De Herreros A. The transcription factor snail is a repressor of E-cadherin gene expression in epithelial tumour cells. Nat Cell Biol 2000; 2:84-9; PMID:10655587; http://dx.doi.org/10.1038/35000034
   PubMed Web of Science ®Google Scholar
• de Herreros AG, Peiro S, Nassour M, Savagner P. Snail family regulation and epithelial mesenchymal transitions in breast cancer progression. J Mammary Gland Biol Neoplasia 2010; 15:135-47; PMID:20455012; http://dx.doi.org/10.1007/s10911-010-9179-8
   PubMed Web of Science ®Google Scholar
• Mimoto R, Taira N, Takahashi H, Yamaguchi T, Okabe M, Uchida K, Miki Y, Yoshida K. DYRK2 controls the epithelial-mesenchymal transition in breast cancer by degrading Snail. Cancer Lett 2013; 339:214-25; PMID:23791882; http://dx.doi.org/10.1016/j.canlet.2013.06.005
   PubMed Web of Science ®Google Scholar
• Ye X, Lee YC, Choueiri M, Chu K, Huang CF, Tsai WW, Kobayashi R, Logothetis CJ, Yu-Lee LY, Lin SH. Aberrant expression of katanin p60 in prostate cancer bone metastasis. Prostate 2012; 72:291-300; PMID:21681775; http://dx.doi.org/10.1002/pros.21431
   PubMed Web of Science ®Google Scholar
• Yamashita S, Chujo M, Moroga T, Anami K, Tokuishi K, Miyawaki M, Kawano Y, Takeno S, Yamamoto S, Kawahara K. DYRK2 expression may be a predictive marker for chemotherapy in non-small cell lung cancer. Anticancer Res 2009; 29:2753-7; PMID:19596956
   PubMed Web of Science ®Google Scholar
• Enomoto Y, Yamashita SI, Yoshinaga Y, Fukami Y, Miyahara S, Nabeshima K, Iwasaki A. Downregulation of DYRK2 can be a predictor of recurrence in early stage breast cancer. Tumour Biol 2014; 35:11021-5; PMID:25095982; http://dx.doi.org/10.1007/s13277-014-2413-z
   PubMed Web of Science ®Google Scholar